PLAY PODCASTS
Dr Diana Sarfati: Director-General of Health on the Ministry of Health brief examining the benefits and risks of puberty blockers

Dr Diana Sarfati: Director-General of Health on the Ministry of Health brief examining the benefits and risks of puberty blockers

Heather du Plessis-Allan Drive · Newstalk ZB

November 21, 20243m 44s

Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

The Director-General of Health says she expects puberty blocker prescriptions to continue to fall. 

The Ministry of Health has released an evidence brief showing a lack of quality evidence backing their effectiveness and safety for gender dysphoria.

It says they should be prescribed by a clinician experienced in gender-affirming care, in a team offering wide support.

Dr Diana Sarfati says use was already declining. 

"The peak prescription for puberty blockers was around 2021- and in the last couple of years, we're already starting to see a drop-off."

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

Topics

healthcarepuberty blockersMinistry of HealthDirector-General of Health